Peginterferon alfa-2b therapy in acute hepatitis C: Impact of onset of therapy on sustained virologic response

Gastroenterology

Volumn 130, Issue 3, 2006, Pages 632-638

  Kamal, Sanaa M ^a,b,c,d   Fouly, Amr E ^b   Kamel, Refaat R ^b   Hockenjos, Bridgette ^c   Al Tawil, Ahmed ^b   Khalifa, Khalifa E ^b   He, Qi ^a   Koziel, Margaret J ^a   El Naggar, Khairy M ^b   Rasenack, Jens ^c   Afdhal, Nezam H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c UNIVERSITY OF FREIBURG   (Germany)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2B;

ADULT; ANXIETY; ARTICLE; BLURRED VISION; CHORIORETINITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; GASTROENTERITIS; GENOTYPE; HEPATITIS C; HUMAN; INSOMNIA; KIDNEY COLIC; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MYCOSIS; NEUTROPENIA; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; URTICARIA; VIREMIA; VIRUS RESISTANCE;

EID: 33644857481     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.01.034     Document Type: Article

References (24)

1. J.H. Hoofnagle Course and outcome of hepatitis C Hepatology 36 Suppl 2002 S21 S29
2. T.J. Liang, B. Rehermann, L.B. Seeff, J.H. Hoofnagle Pathogenesis, natural history, treatment, and prevention of hepatitis C Ann Intern Med 132 2000 296 305
3. M.J. Alter The epidemiology of acute and chronic hepatitis C Clin Liver Dis 1 1997 559 568
4. J.R. Orland, T.L. Wright, S. Cooper Acute hepatitis C Hepatology 33 2001 321 327
5. S.M. Kamal, A. Amin, M. Madwar Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients J Virol 78 2004 12252 12258
6. H. Nakayama, Y. Sugai, S. Ikeya, J. Inoue, T. Nishizawa, H. Okamoto Molecular investigation of interspousal transmission of hepatitis C virus in two Japanese patients who acquired acute hepatitis C after 40 or 42 years of marriage J Med Virol 75 2005 258 266
7. M. Omata, O. Yokosuka, S. Takano Resolution of acute hepatitis C after therapy with natural beta interferon Lancet 338 1991 914 915
8. S.J. Hwang, S.D. Lee, C.Y. Chan, R.H. Lu, K.J. Lo A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C J Hepatol 21 1994 831 836
9. P. Lampertico, M. Rumi, R. Romeo A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C Hepatology 19 1994 19 22
10. W. Vogel, I. Graziadei, F. Umlauft High-dose interferon-alfa-2b treatment prevents chronicity in acute hepatitis C a pilot study Dig Dis Sci 41 Suppl 1996 81S 85S
11. G. Calleri, P. Colombatto, M. Gozzelino Natural beta interferon in acute type-C hepatitis patients a randomized controlled trial Ital J Gastroenterol Hepatol 30 1998 181 184
12. E. Jaeckel, M. Cornberg, H. Wedemeyer Treatment of acute hepatitis C with interferon alfa-2b N Engl J Med 345 2001 1452 1457
13. J.T. Gerlach, H.M. Diepolder, R. Zachoval Acute hepatitis C high rate of both spontaneous and treatment-induced viral clearance Gastroenterology 125 2003 80 88
14. H. Nomura, S. Sou, H. Tanimoto, T. Nagahama, Y. Kimura, I. Hayashi Short-term interferon-alfa therapy for acute hepatitis C Hepatology 39 2004 1213 1219
15. M.P. Manns, J.G. McHutchison, S.C. Gordon Peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C a randomized trial Lancet 358 2001 958 965
16. M.W. Fried, M.L. Shiffman, R. Reddy Peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
17. S. Zeuzem, S.V. Feinman, J. Rasenack Peginterferon alfa-2a in patients with chronic hepatitis C N Engl J Med 343 2000 1666 1672
18. S.M. Kamal, A. El Tawil, T. Nakano Peginterferon-alpha 2b and ribavirin therapy in chronic hepatitis C genotype 4 impact of treatment duration and viral kinetics on sustained virologic response Gut 54 2005 858 866
19. K.L. Lindsay, C. Trepo, T. Heintges A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C Hepatology 34 2001 395 403
20. S.M. Kamal, A. Ismail, C.S. Graham Pegylated interferon alpha therapy in acute hepatitis C relation to hepatitis C virus-specific T cell response kinetics Hepatology 39 2004 1721 1731
21. P. Farci, R. Strazzera, H.J. Alter, S. Farci, D. Degioannis, A. Coiana Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome Proc Natl Acad Sci U S A 99 2002 3081 3086
22. J. Wiegand, E. Jackel, M. Cornberg Long-term follow-up after successful interferon therapy of acute hepatitis C Hepatology 40 2004 98 107
23. T. Gerlach, H. Diepolder, M. Jung Recurrence of hepatitis C virus after loss of virus specific CD 4 + T-cell response in acute hepatitis C Gastroenterology 117 1999 993-941
24. S.M. Kamal, J.W. Rasenack, L. Bianchi Acute hepatitis C without and with schistosomiasis correlation with hepatitis C-specific CD4 (+) T-cell and cytokine response Gastroenterology 121 2001 646 656